Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 202 (RNA5SP202) is a human genomic locus classified as a pseudogene derived from the 5S ribosomal RNA gene[2]. 5S ribosomal RNA is a core structural and functional constituent of the large ribosomal subunit in all domains of life, except for fungal and animal mitochondrial ribosomes[1][3][5]. Pseudogenes such as RNA5SP202 are nonfunctional copies or remnants of functional genes, often generated via gene duplication or retrotransposition. Unlike functional 5S rRNA genes, RNA5SP202 does not produce a functional rRNA product and is not incorporated into ribosomes[2]. While some pseudogenes have been implicated in gene regulation, cancer biology, or as decoys for regulatory RNAs, specific functional or disease associations for RNA5SP202 have not been established in available databases or literature as of June 2024[2][4]. Key clarifications: - RNA5SP202 is a pseudogene, not a protein, enzyme, receptor, transporter, or traditional therapeutic target. - No evidence exists that makes RNA5SP202 a therapeutic, diagnostic, or pharmacological target. - The information on RNA5SP202 in gene databases is minimal, limited to its annotation as a pseudogene and its aliases[2]. - There is no indication of misspelling; however, the molecule is not a conventional therapeutic target and has no established biological or clinical function. Summary of conventions: - The canonical full name is "RNA, 5S ribosomal pseudogene 202". - The abbreviation "RNA5SP202" matches gene databases and standard nomenclature[2]. - Classified under "Other" (Pseudogene, Noncoding RNA) as it is not a member of major target families like receptors, enzymes, ion channels, etc. - No known drug interactions, safety concerns, biomarkers, or mechanisms of action; no direct role in disease is established.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 202 (RNA5SP202).